Orna Therapeutics Alternatives & Competitors
12 companies similar to Orna Therapeutics — Wholly Owned Subsidiary of Eli Lilly and Company
Companies similar to Orna Therapeutics
Rgenta Therapeutics Inc.
We unlock the therapeutic potentials of highly disease-relevant targets undruggable by sma...
Woburn, United States
Yuanyin Bio
Pioneering the future of medicine with groundbreaking RNA technology to tackle unmet clini...
RIGImmune Inc.
Targeted non-LNP Delivery of RNA Therapeutics
Farmington, United States
CAMP4 Therapeutics
Advancing a pipeline of ASO-based, RNA-targeting therapeutics with the aim to restore heal...
Cambridge, United States
Rival Readout
Competing with Orna Therapeutics? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
NanoVation Therapeutics™
Delivering tomorrow's genetic medicines, today™
Canada
Lumos Pharma
Transforming Lives with Rare Focus
Austin, United States
Arrakis Therapeutics
Arrakis is on a path to bring powerful new RNA-targeted small molecule (rSM) therapies to...
Waltham, United States
Affinia Therapeutics
Building the next generation of gene therapies
Waltham, United States
Kernal Biologics
KernalBio creates mRNA therapies that instruct specific cells on how to make their own med...
Cambridge, United States
ROME Therapeutics
Harnessing the power of the repeatome to develop a new class of therapies for cancer and a...
Boston, United States
Pantherna Therapeutics GmbH
Developing novel mRNA-based therapeutics
Hennigsdorf, Germany
About Orna Therapeutics
Orna Therapeutics, founded in 2019, is a cutting-edge biotechnology company that is redefining the scope of RNA therapeutics. Positioned as "Ahead of the Curve," the company is pioneering a novel circular RNA technology platform known as oRNA®, alongside innovative lipid nanoparticle (LNP) delivery solutions. These adv...
Development of circular RNA therapeutics, Implementation of in vivo CAR-T cell therapies, Tailored LNP delivery systems
Patients with B cell-driven autoimmune diseases, Patients with oncology-related conditions, Biopharmaceutical partners
RNA Therapeutics, Circular RNA, ORNA Technology, Lipid Nanoparticle Delivery, In Vivo Therapies, Disease Treatment, Protein Expression, Therapeutic Development, Genetic Engineering, Drug Delivery Solutions, Novel Technology
B2B, Platform
Licensing, Performance Based
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Orna Therapeutics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Orna Therapeutics on 9 Jun 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
